logo
Fondation Santé
                 
  Internships || Student Awards ||  

RESEARCH GRANTS IN BIOMEDICAL SCIENCES

Recognizing that deserving scientists are not always adequately funded in Greece, Fondation Sante initiated its Research Grants in Biomedical Sciences Program in 2012. The grants support existing research teams at the level of €25,000 for one year with the possibility of a one-time renewal depending on progress.

The modest size of these grants cannot support full-fledged research programs. They are, designed, instead, to help research teams begin new projects or extend an existing program in new directions. Finally, through this program we wish to support Principal Investigators and make a statement that the quality of their work remains high in despite ever decreasing resources.

The submission deadline for this year is September 1, 2017.

Applications are evaluated by our scientific advisory board, strictly on the basis of scientific merit as judged. Among the proposals that are considered meritorious, we will take into account the level of existing funding. Investigators who have already received Fondation Sante support in the past are not excluded from applying again.

Please note that the ranking of the applications is not publicly announced and we do not provide a written evaluation of the proposals.

Scientific Advisory Board

  • Dr. Spyros Artavanis-Tsakonas, Chair
    Professor Artavanis-Tsakonas’ laboratory at the Harvard Medical School has been focused for many years on the use of model organisms to define critical targets and pathways important in development and disease. The identification and elucidation of much of the biology of the Notch pathway traces back to his laboratory. In the past few years his work has been and is focused on the identification and analysis of pathways involved in neurodegeneration.

    From 2012 to March 2017 he was the Chief Scientific Officer for Biogen. He is now Professor Emeritus in the Department of Cell Biology which he joined originally in 1998 and was the founding Director of the Developmental and Regenerative Biology Program at Harvard Medical School. From 1999-2007 he was also the Isselbacher-Schwartz Professor, Massachusetts General Hospital Cancer Center.

    Dr. Artavanis-Tsakonas' previous positions include: Professor, Collège de France, holding the Chair of Biology and Genetics of Development from 1999-2012; Professor, Department of Biology, Yale University; Professor, Department of Cell Biology, Yale University School of Medicine and Director of the Biological Sciences Division at Yale; he was a Howard Hughes Medical Institute Investigator from 1981 to 1998 when he left for Harvard. He is the Founding Director of The Department of Genetics and Developmental Biology at Institute Curie, Paris, 2007-2009.

  • Dr. Sidney Altman
    Professor Altman is a biochemist and a Professor of biology at Yale University who served as the Dean of Yale College for several years. He is a member of the National Academy of Sciences (U.S.) and in 1989 received the Nobel Prize for Chemistry. Professor Altman is a fellow of the American Academy of Arts and Sciences.

  • Dr. David Baltimore
    Professor Baltimore is a biologist, university administrator, and one of the 1975 Recipients of the Nobel Prize in Physiology or Medicine. He served as President of the California Institute of Technology (Caltech) from 1997 to 2006 and is currently the Robert A. Millikan Professor of Biology at Caltech. He also served as President of Rockefeller University from 1990 to 1991 and was President of the American Association for the Advancement of Science in 2007.

  • Dr. Edith Heard
    Professor of Epigenetics and Cellular Memory at the Collège de France, director of the Genetics and Developmental Biology Department, Institut Curie, Paris.

    Professor Edith Heard was trained as a geneticist at Cambridge University and carried out her PhD at the ICRF (London). During her post doc at the Pasteur Institute in Paris, she began her work on mammalian X-chromosome inactivation and the role and regulation of the Xist non-coding RNA. She now heads the Mammalian Developmental Epigenetics team at the Institut Curie and is director of the Genetics and Developmental Biology Department. She is also Professor of Epigenetics and Cellular Memory at the Collège de France. Her laboratory focuses on epigenetic processes in mammals, with particular interest in the role of non-coding RNAs, nuclear organization and chromatin structure in the establishment and maintenance of differential expression patterns during early development and in disease.

    Through her studies on X-chromosome inactivation, Professor Heard has made several discoveries in epigenetics. Her lab developed single- cell techniques enabling the analysis of fixed and living embryos and embryonic stem cells. These revealed that X-inactivation is a highly dynamic process during early embryogenesis, with multiple waves of silencing and reactivation. The Heard lab also performed work revealing that in addition to epigenetic modifications, chromosome organization (including topologically associating domains, TADs) and nuclear compartmentalization are important players in the initiation and maintenance of X inactivation. In addition to their extensive investigation of X inactivation, the Heard lab’s most recent work has revealed that numerous autosomal genes can become monoallelically expressed during development, with important implications for disease as several of these genes have been implicated in autosomal dominant disorders.

  • Dr. Daniel Louvard
    Professor Daniel Louvard, Professor Emeritus at the Institut Pasteur and former Director of the Research Center of Institut Curie, Paris, President of the International Scientific Advisory Board of the IECB, and member of the Scientific Advisory Committee of the European Molecular Biology Laboratory (EMBL).

    After two PHDs, one in Biochemistry and one in Physics, Professor Louvard was appointed group leader at the EMBL in 1978, when the lab was created. He then moved back to France in 1982 and took a CNRS research director position at the Institut Pasteur. There, he headed the Department of Molecular Biology from 1988 to 1990. Author of over 245 publications and 20 patents, he has been since 1993 the director of the research centre of the Institut Curie.

    Professor Louvard is a founding member of the IECB’s International Scientific Advisory Board: He also actively participates in prestigious scientific boards (EMBO, Academy of Sciences, Academia Europa, European Academy of Cancer Sciences).

  • Dr. Gerald Rubin
    Professor Rubin is a geneticist who is Scientific Vice President and Director of the Janelia Farm Research Campus, a research facility established in 2006 by the Howard Hughes Medical Institute near Ashburn, Virginia in the U.S.A. Previously, Dr. Rubin was Professor of Genetics, Genomics, and Development at the University of California. He is a member of the National Academy of Sciences (U.S.), the Institute of Medicine, and the American Academy of Arts and Sciences.

  • Dr. Marc Tessier-Lavigne
    Professor Tessier-Lavigne joined Rockefeller University as president and professor in March 2011. He was formerly executive vice president for research and the chief scientific officer at Genentech. He is the first industry executive to assume the presidency of Rockefeller University. He is a member of the National Academy of Sciences (U.S.), a fellow of The Royal Society and the Academy of Medical Sciences in the UK, a fellow of The Royal Society of Canada, and a fellow of the American Association for the Advancement of Science.
Review Cycle - 2017

The SAB considered twelve proposals to be of the highest quality and deserving of funding. The Board of Fondation Santé accepted the recommendation of the SAB and will fund the work of the following scientists:

  • Yiorgos Apidianakis, Department of Biological Sciences, University of Cyprus
  • Christos Delidakis,University of Crete, (IMBB-FORTH), Heraklion, Crete
  • Panayotis Politis, Biomedical Research Foundation Academy of Athens
  • Efthimios Skoulakis, Neurobiology Division, BSRC "Alexander Fleming", Vari
  • Vasiliki Koliaraki, Institute of Molecular Biology and Genetics, BSRC "Alexander Fleming", Vari
  • Angeliki Magklara, Faculty of Medicine, School of Life Sciences, University of Ioannina
  • Ilias A. Mylonis, Laboratory of Biochemistry, Faculty of Medicine, University of Thessaly, Larissa
  • Irini Skaliora, Neurophysiology Laboratory, Biomedical Research Foundation of the Academy of Athens
  • Leonidas Stefanis, Department of Neurology, University of Athens Medical School
  • Dimitra Thomaidou, Department of Neurobiology & Imaging Unit, Hellenic Pasteur Institute, Athens
  • George Zachos, Department of Biology, University of Crete, Heraklion, Crete
  • Christos Zervas, Biomedical Research Foundation Academy of Athens
Review Cycle - 2016

The SAB considered ten proposals to be of the highest quality and deserving of funding. The Board of Fondation Santé accepted the recommendation of the SAB and will fund the work of the following scientists:

  • Epaminondas Doxakis, Biomedical Research Foundation of the Academy of Athens
  • Aristides Eliopoulos, University of Crete Medical School
  • Pantelis Hatzis, BSRC ‘Alexander Fleming’
  • Apostolos Klinakis, Biomedical Research Foundation of the Academy of Athens
  • Zoe Lygerou, School of Medicine, University of Patras
  • Petros Marangos, Dept. of Biological Applications and Technology, University of Ioannina
  • Sifis Papamatheakis, School of Sciences, University of Crete, (IMBB-FORTH)
  • Maria Roubelakis, Laboratory of Biology, Medical School of Athens
  • Inga Siden-Kiamos, Institute of Molecular Biology and Biotechnology, Foundation for Research and Technology (IMBB-FORTH)
  • Constantinos Stathopoulos, University of Patras, School of Medicine, Dept. of Biochemistry
Review Cycle - 2015

The SAB considered six proposals to be of the highest quality and deserving of funding. The Board of Fondation Santé accepted the recommendation of the SAB and will fund the work of the following scientists:

  • George Diallinas,University of Athens
  • Georgia G. Gregoriou, University of Crete
  • Artemis Hadzigeorgiou, University of Thessaly
  • Rebecca Matsas, Hellenic Pasteur Institute
  • Nektarios Tavernarakis, University of Crete, IMBB-FORTH
  • Laskaro Zagoraiou, Biomedical Research Foundation Academy of Athens
Review Cycle - 2014

More than sixty proposals were submitted for the current review cycle from several academic and research institutions. The SAB considered seven proposals to be of the highest quality and deserving of funding. The Board of Fondation Santé accepted the recommendation of the SAB and will fund the work of the following scientists:

  • Antigone Dimas, Institute of Molecular Biology and Genetics, BSRC "Alexander Fleming"
  • Evangelos Kolettas, School of Medicine, University of Ioannina & BRD-IMBB/FORTH
  • Panayotis Politis, Biomedical Research Foundation Academy of Athens
  • Despina Sanoudou, Biomedical Research Foundation Academy of Athens
  • Charalampos Spilianakis, University of Crete, (IMBB-FORTH)
  • George Zachos, Department of Biology, University of Crete
  • Christos Zervas, Biomedical Research Foundation Academy of Athens
Review Cycle - 2013

More than forty proposals were submitted for the 2013 review cycle from several academic and research institutions. The SAB considered four proposals to be of the highest quality and deserving of funding. The Board of Fondation Santé accepted the recommendation of the SAB and in March 2012 funded the work of the following four scientists:

  • Yiorgos Apidianakis, Department of Biological Sciences, University of Cyprus
  • Pantelis Hatzis, Institute of Molecular Biology and Genetics, BSRC "Alexander Fleming"
  • Chrysoula Pitsouli, Department of Biological Sciences, University of Cyprus
  • Efthimios Skoulakis, Institute of Molecular Biology and Genetics, BSRC "Alexander Fleming"
  • Georgia Sotiropoulou, Department of Pharmacy, School of Health Sciences, University of Patras
  • Georgina Xanthou, Biomedical Research Foundation Academy of Athens
Review Cycle - 2012

For the 2012 review cycle over twenty proposals were submitted from several Greek academic and research institutions. The SAB recommended that four proposals were of the highest quality and deserving of funding. The Board of Fondation Santé accepted the recommendation of the SAB and in March 2012 funded the work of the following four scientists:

  • Dimitris Beis,Biomedical Research Foundation Academy of Athens
  • Apostolos Klinakis,Biomedical Research Foundation Academy of Athens
  • Christos Delidakis,Institute of Molecular Biology & Biotechnology, Heraklion
  • Stavros Taraviras,Medical School, University of Patras